Goldman Sachs maintains a "Buy" rating for Colgate-Palmolive (NYSE:CL), raising the price target from $91 to $94.The company reported a 4% increase in earnings per share and a 5.8% rise in net sales for the fourth quarter of 2025.Effective pricing strategies and robust brand leadership in oral care and pet nutrition segments drive growth, particularly in Latin America.Colgate-Palmolive (NYSE:CL) is a global leader in consumer products, specializing in oral care, personal care, home care, and pet nutrition. ...